Jeffrey Daniel Bernstein net worth and biography

Jeffrey Bernstein Biography and Net Worth

Director of Privia Health Group

Jeff Bernstein has been a managing director in the Asset Management Division of Goldman Sachs (GS AMD) since January 2020, having previously held the positions of Vice President and Associate beginning in July 2010, focusing on private equity activities in the healthcare sector. Prior to joining GS AMD, Mr. Bernstein was in the Healthcare Group in Goldman Sachs’ Investment Banking Division from June 2008 to June 2010. Mr. Bernstein serves on the boards of Brighton Health Plan Solutions, Capital Vision Services (referred to publicly as MyEyeDr.) and Sapphire Digital,and is a board observer at Advanced Recovery Systems. He previously served on the boards of Golden State Medical Supply and Upstream Rehabilitation. Mr. Bernstein received an AB in Economics, magna cum laude, and a certificate in Finance from Princeton University.

How do I contact Jeffrey Daniel Bernstein?: The corporate mailing address for Mr. Bernstein and other Privia Health Group executives is , , . Privia Health Group can also be reached via phone at 571-366-8850 and via email at [email protected]. Learn More on Jeffrey Daniel Bernstein's contact information.
Has Jeffrey Daniel Bernstein been buying or selling shares of Privia Health Group?: Jeffrey Daniel Bernstein has not been actively trading shares of Privia Health Group in the last ninety days. Most recently, Jeffrey Daniel Bernstein sold 2,505,732 shares of the business's stock in a transaction on Tuesday, November 23rd. The shares were sold at an average price of $27.70, for a transaction totalling $69,408,776.40. Learn More on Jeffrey Daniel Bernstein's trading history.
Who are Privia Health Group's active insiders?: Privia Health Group's insider roster includes Thomas Bartrum (EVP), Jeffrey Bernstein (Director), Parth Mehrotra (COO), Matthew Morris (CEO), David Mountcastle (CFO), and William Sullivan (Director). Learn More on Privia Health Group's active insiders.
Are insiders buying or selling shares of Privia Health Group?: In the last year, Privia Health Group insiders bought shares 4 times. They purchased a total of 293,235 shares worth more than $4,745,481.05. In the last year, insiders at the sold shares 11 times. They sold a total of 206,483 shares worth more than $3,914,638.10. The most recent insider tranaction occured on September, 10th when CEO Parth Mehrotra sold 135,142 shares worth more than $2,500,127.00. Insiders at Privia Health Group own 14.2% of the company. Learn More about insider trades at Privia Health Group.
Information on this page was last updated on 9/10/2024.

Jeffrey Daniel Bernstein Insider Trading History at Privia Health Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/23/2021	Sell	2,505,732	$27.70	$69,408,776.40

Jeffrey Daniel Bernstein Buying and Selling Activity at Privia Health Group

Privia Health Group Company Overview

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Today's Range

Now: $20.79

$20.63

$21.13

50 Day Range

MA: $18.86

$16.82

$22.80

2 Week Range

Now: $20.79

$15.92

$24.30

Volume

449,129 shs

Average Volume

919,956 shs

Market Capitalization

$2.49 billion

P/E Ratio

207.92

Dividend Yield

N/A

Beta

0.76

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.